IL17RB and breast carcinoma: The Breast Cancer Index (BCI), a gene expression-based signature, is a continuous risk prediction model that combines the gene expression profiles of the HOXB13/IL17BR ratio (H:I) and the Molecular Grade Index (MGI) [6,7].